Eris Natco Semaglutide Launch India Partnership Targets Diabetes and Obesity Market
The Eris Natco semaglutide launch India partnership marks a significant development in the country’s pharmaceutical landscape as Eris Lifesciences joins hands with Natco Pharma to […]